FBR initiates coverage on numerous healthcare names

|By:, SA News Editor

Alkermes (ALKS) started at Market Perform. Price target is $31.

Sarepta Therapeutics (SRPT) started at Market Perform. Price target is $48.

Regulus Therapeutics (RGLS) started at Outperform. Price target is $15.

Forest Labs (FRX) started at Market Perform. Price target is $48.

Supernus Pharmaceuticals (SUPN) started at Outperform. Price target is $12.

Raptor Pharmaceuticals (RPTP) started at Outperform. Price target is $17.

Kythera Biopharmaceuticals (KYTH) started at Outperform. Price target is $58.

Endo Pharmaceuticals (ENDP) started at Market Perform. Price target is $40.

Valeant Pharmaceuticals (VRX) started at Outperform. Price target is $130.

Aegerion Pharmaceuticals (AEGR) started at Outperform. Price target is $105.